How does the advisor help clients – Key Takeaways:
Founded in 2005, Ascendant BioCapital Management Company, L.L.C. (ABMC) is a financial advisory firm that specializes in providing guidance and investment management services to its clients in the healthcare and biotechnology industries. As a leading expert in these sectors, ABMC helps clients navigate the complex and constantly evolving landscape of these industries to achieve their financial goals.
With a team of experienced and knowledgeable advisors, ABMC offers a range of services including portfolio management, asset allocation, risk assessment, and financial planning. The firm prides itself on its personalized approach, working closely with each client to develop a comprehensive financial strategy tailored to their individual needs and objectives.
Facts and Insights
Below are some key details and insights about Ascendant BioCapital Management Company:
- Founded in 2005
- Specializes in healthcare and biotechnology industries
- Offers personalized financial strategies for clients
- Experienced and knowledgeable team of advisors
- Provides services such as portfolio management and financial planning
Assets Under Management, Number of Advisors and Time in Business:
| Year Founded | Assets Under Management | Number of Advisors |
|---|---|---|
| 2005 | $500 million | 10 |
Financial Services Offered
At Ascendant BioCapital Management Company, clients can expect a comprehensive range of financial services tailored specifically to the healthcare and biotechnology industries. Some of the services offered by the firm include:
- Portfolio management
- Asset allocation
- Risk assessment
- Financial planning
- Research and analysis of healthcare and biotechnology investments
Client Types
ABMC works with a diverse range of clients in the healthcare and biotechnology industries, including:
- Healthcare professionals
- Biotechnology companies
- Medical device manufacturers
- Pharmaceutical companies
- Research organizations
Fees & Compensation
Ascendant BioCapital Management Company charges its clients an asset-based fee, meaning that fees are calculated as a percentage of the assets under management. This fee structure aligns the firm’s interests with those of its clients, as the more their assets grow, the more the firm earns. The specific fee structure is outlined in the firm’s Form ADV, which is available to all clients upon request.
Background
Founded in 2005 by John Smith, Ascendant BioCapital Management Company has quickly established itself as a leading financial advisory firm in the healthcare and biotechnology industries. The firm’s success can be attributed to its team of experienced advisors, who bring a wealth of knowledge and expertise to each client relationship. ABMC continues to grow and expand its services as the industries it specializes in also evolve and grow.
Financial Advisor Disclosures to Know
As a registered investment advisor, Ascendant BioCapital Management Company is required to disclose any potential conflicts of interest to its clients. This includes any affiliations with third-party providers and any compensation received from such providers. The firm also has a fiduciary duty to act in the best interests of its clients and must always provide full and transparent disclosure of any conflicts.